Vanc Pharmaceuticals Inc

[elephant]

While I agree with you about the DIN delay, I can't agree that the nr's have been fluff. In a couple months when they announce that the clinical tests have been successful and they're going to human trials I think those fluffy nr's will firm up nicely into solid company building (not to mention the dramatically increased sp when the human trials are successful and we're marketing a powerful new treatment for eczema and athlete's foot). They may not be the nr's we want right now, but as I mentioned earlier, Alda has been chugging along with research, growth and development the way an industrious company should and our profits may only be incidental to their plans.